Opportunities Preloader

Please Wait.....

Report

Prostate Cancer Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2030

Market Report I 2023-08-29 I 255 Pages I Infinium Global Research and Consulting Solutions

The report on the global prostate cancer market provides qualitative and quantitative analysis for the period from 2021-2030. The global prostate cancer market was valued at USD 12.32 billion in 2022 and is expected to reach USD 29.52 billion in 2030, with a CAGR of 10.0% during the forecast period 2023-2030. The study on prostate cancer market covers the analysis of the leading geographies such as North America, Europe, Asia Pacific, and RoW for the period of 2021-2030.
Demand for prostate therapies is increasing as prostate cancer cases are becoming more common. For instance, Prostate cancer is the most common cancer among men, except for skin cancer. In 2023, an estimated 288,300 men in the United States will be diagnosed with prostate cancer. Worldwide, an estimated 1,414,259 people were diagnosed with prostate cancer in 2020. It is the fourth most diagnosed cancer in the world. Rising healthcare expenditure and reimbursement support positively impact the market of Prostate cancer treatment are the factors projected to propel the market within the forecast period. The Federal Government annually invests millions of dollars in prostate cancer research through the Prostate Cancer Research Program (PCRP) and the National Institutes of Health (NIH). NCI Funded Research Portfolio (NFRP) has over $255 million allocated for prostate cancer research.
The global prostate cancer market is bifurcated By Drug Class, End User, and Distribution Channel. By Drug Class the segment is further segmented into Hormonal Therapy, Chemotherapy, Immunotherapy, Targeted Therapy, and others. The hormonal therapy segment is anticipated to dominate the market growth during the forecast period. The growth of the segment is attributed to the various advantages as Hormone therapy is also called androgen suppression therapy. The goal of this treatment is to reduce levels of male hormones, called androgens, in the body, or to stop them from fueling prostate cancer cell growth. Androgens stimulate prostate cancer cells to grow. Furthermore, in 85% to 90% of cases of advanced prostate cancer, hormone therapy can shrink the tumor. Hormone therapy may be used to reduce or prevent symptoms in men with prostate cancer who are not able to have surgery or radiation therapy.
The global prostate cancer market is segmented into Asia Pacific, North America, Europe, the Middle East & Africa, and South America. North America is predicted to be the fastest-growing region within the global market share. Since the disease is becoming more common there is a great need for prostate cancer therapy items in the area. However, growth in North America is responsible for the launch of promising new medications in the biologics and hormone therapy sectors. The anticipated launch of a few pipeline medications is anticipated to fuel the local market during the projection period. For instance, the Pluvicto medication, which will be used to treat adult patients with prostate cancer, received FDA approval for an advanced accelerator application in March 2022. Over the course of the projection period, the market is expected to be driven by a solid pipeline and government backing for innovation.

Report Findings
1) Drivers
- Demand for prostate therapies is increasing as prostate cancer cases are becoming more common this factor drives the prostate cancer market.
- Rising healthcare expenditure and reimbursement support positively impact the market of prostate cancer treatment.
2) Restraints
- High cost of treatment, complications, and side effects caused due to treatment can hamper the prostate cancer market growth.
3) Opportunities
- The emergence of strong pipeline drugs and the presence of new prostate cancer treatments will escalate the growth rate of the prostate cancer market.

Research Methodology
A) Primary Research
Our primary research involves extensive interviews and analysis of the opinions provided by the primary respondents. The primary research starts with identifying and approaching the primary respondents, the primary respondents are approached include
1. Key Opinion Leaders associated with Infinium Global Research
2. Internal and External subject matter experts
3. Professionals and participants from the industry
Our primary research respondents typically include
1. Executives working with leading companies in the market under review
2. Product/brand/marketing managers
3. CXO level executives
4. Regional/zonal/ country managers
5. Vice President level executives.
B) Secondary Research
Secondary research involves extensive exploring through the secondary sources of information available in both the public domain and paid sources. At Infinium Global Research, each research study is based on over 500 hours of secondary research accompanied by primary research. The information obtained through the secondary sources is validated through the crosscheck on various data sources.
The secondary sources of the data typically include
1. Company reports and publications
2. Government/institutional publications
3. Trade and associations journals
4. Databases such as WTO, OECD, World Bank, and among others.
5. Websites and publications by research agencies

Segment Covered
The global prostate cancer market is segmented on the basis of drug class, distribution channel, and end user.

The Global Prostate Cancer Market by Drug Class
- Hormonal Therapy
- Immunotherapy
- Targeted Therapy
- Others

The Global Prostate Cancer Market by Distribution Channel
- Hospital Pharmacies
- Drug Store & Retail Pharmacies
- Online Pharmacies
- Others

The Global Prostate Cancer Market by End User
- Clinic
- Hospital
- Others

Company Profiles
The companies covered in the report include
- Pfizer Inc.
- AbbVie Inc.
- AstraZeneca
- Johnson & Johnson Services, Inc.
- Merck & Co., Inc.
- Sanofi
- Bayer AG
- Clovis Oncology, Inc.
- Eli Lilly and Company
- Astellas Pharma Inc.

What does this Report Deliver?
1. Comprehensive analysis of the global as well as regional markets of the prostate cancer market.
2. Complete coverage of all the segments in the prostate cancer market to analyze the trends, developments in the global market and forecast of market size up to 2030.
3. Comprehensive analysis of the companies operating in the global prostate cancer market. The company profile includes analysis of product portfolio, revenue, SWOT analysis and latest developments of the company.
4. IGR- Growth Matrix presents an analysis of the product segments and geographies that market players should focus to invest, consolidate, expand and/or diversify.

Table of Content

Chapter 1. Preface
1.1. Report Description
1.2. Research Methods
1.3. Research Approaches

Chapter 2. Executive Summary
2.1. Prostate Cancer Market Highlights
2.2. Prostate Cancer Market Projection
2.3. Prostate Cancer Market Regional Highlights

Chapter 3. Global Prostate Cancer Market Overview
3.1. Introduction
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
3.3. Porter's Five Forces Analysis
3.4. IGR-Growth Matrix Analysis
3.4.1. IGR-Growth Matrix Analysis by Drug Class
3.4.2. IGR-Growth Matrix Analysis by Distribution Channel
3.4.3. IGR-Growth Matrix Analysis by End User
3.4.4. IGR-Growth Matrix Analysis by Region
3.5. Value Chain Analysis of Prostate Cancer Market

Chapter 4. Prostate Cancer Market Macro Indicator Analysis

Chapter 5. Company Profiles and Competitive Landscape
5.1. Competitive Landscape in the Global Prostate Cancer Market
5.2. Companies Profiles
5.2.1. Pfizer Inc.
5.2.2. AbbVie Inc.
5.2.3. AstraZeneca
5.2.4. Johnson & Johnson Services, Inc.
5.2.5. Merck & Co., Inc.
5.2.6. Sanofi
5.2.7. Bayer AG
5.2.8. Clovis Oncology, Inc.
5.2.9. Eli Lilly and Company
5.2.10. Astellas Pharma Inc.

Chapter 6. Global Prostate Cancer Market by Drug Class
6.1. Hormonal Therapy
6.2. Immunotherapy
6.3. Targeted Therapy
6.4. Others

Chapter 7. Global Prostate Cancer Market by Distribution Channel
7.1. Hospital Pharmacies
7.2. Drug Store & Retail Pharmacies
7.3. Online Pharmacies
7.4. Others

Chapter 8. Global Prostate Cancer Market by End User
8.1. Clinic
8.2. Hospital
8.3. Others

Chapter 9. Global Prostate Cancer Market by Region 2023-2030
9.1. North America
9.1.1. North America Prostate Cancer Market by Drug Class
9.1.2. North America Prostate Cancer Market by Distribution Channel
9.1.3. North America Prostate Cancer Market by End User
9.1.4. North America Prostate Cancer Market by Country
9.1.4.1. The U.S. Prostate Cancer Market
9.1.4.1.1. The U.S. Prostate Cancer Market by Drug Class
9.1.4.1.2. The U.S. Prostate Cancer Market by Distribution Channel
9.1.4.1.3. The U.S. Prostate Cancer Market by End User
9.1.4.2. Canada Prostate Cancer Market
9.1.4.2.1. Canada Prostate Cancer Market by Drug Class
9.1.4.2.2. Canada Prostate Cancer Market by Distribution Channel
9.1.4.2.3. Canada Prostate Cancer Market by End User
9.1.4.3. Mexico Prostate Cancer Market
9.1.4.3.1. Mexico Prostate Cancer Market by Drug Class
9.1.4.3.2. Mexico Prostate Cancer Market by Distribution Channel
9.1.4.3.3. Mexico Prostate Cancer Market by End User
9.2. Europe
9.2.1. Europe Prostate Cancer Market by Drug Class
9.2.2. Europe Prostate Cancer Market by Distribution Channel
9.2.3. Europe Prostate Cancer Market by End User
9.2.4. Europe Prostate Cancer Market by Country
9.2.4.1. Germany Prostate Cancer Market
9.2.4.1.1. Germany Prostate Cancer Market by Drug Class
9.2.4.1.2. Germany Prostate Cancer Market by Distribution Channel
9.2.4.1.3. Germany Prostate Cancer Market by End User
9.2.4.2. United Kingdom Prostate Cancer Market
9.2.4.2.1. United Kingdom Prostate Cancer Market by Drug Class
9.2.4.2.2. United Kingdom Prostate Cancer Market by Distribution Channel
9.2.4.2.3. United Kingdom Prostate Cancer Market by End User
9.2.4.3. France Prostate Cancer Market
9.2.4.3.1. France Prostate Cancer Market by Drug Class
9.2.4.3.2. France Prostate Cancer Market by Distribution Channel
9.2.4.3.3. France Prostate Cancer Market by End User
9.2.4.4. Italy Prostate Cancer Market
9.2.4.4.1. Italy Prostate Cancer Market by Drug Class
9.2.4.4.2. Italy Prostate Cancer Market by Distribution Channel
9.2.4.4.3. Italy Prostate Cancer Market by End User
9.2.4.5. Rest of Europe Prostate Cancer Market
9.2.4.5.1. Rest of Europe Prostate Cancer Market by Drug Class
9.2.4.5.2. Rest of Europe Prostate Cancer Market by Distribution Channel
9.2.4.5.3. Rest of Europe Prostate Cancer Market by End User
9.3. Asia Pacific
9.3.1. Asia Pacific Prostate Cancer Market by Drug Class
9.3.2. Asia Pacific Prostate Cancer Market by Distribution Channel
9.3.3. Asia Pacific Prostate Cancer Market by End User
9.3.4. Asia Pacific Prostate Cancer Market by Country
9.3.4.1. China Prostate Cancer Market
9.3.4.1.1. China Prostate Cancer Market by Drug Class
9.3.4.1.2. China Prostate Cancer Market by Distribution Channel
9.3.4.1.3. China Prostate Cancer Market by End User
9.3.4.2. Japan Prostate Cancer Market
9.3.4.2.1. Japan Prostate Cancer Market by Drug Class
9.3.4.2.2. Japan Prostate Cancer Market by Distribution Channel
9.3.4.2.3. Japan Prostate Cancer Market by End User
9.3.4.3. India Prostate Cancer Market
9.3.4.3.1. India Prostate Cancer Market by Drug Class
9.3.4.3.2. India Prostate Cancer Market by Distribution Channel
9.3.4.3.3. India Prostate Cancer Market by End User
9.3.4.4. South Korea Prostate Cancer Market
9.3.4.4.1. South Korea Prostate Cancer Market by Drug Class
9.3.4.4.2. South Korea Prostate Cancer Market by Distribution Channel
9.3.4.4.3. South Korea Prostate Cancer Market by End User
9.3.4.5. Australia Prostate Cancer Market
9.3.4.5.1. Australia Prostate Cancer Market by Drug Class
9.3.4.5.2. Australia Prostate Cancer Market by Distribution Channel
9.3.4.5.3. Australia Prostate Cancer Market by End User
9.3.4.6. Rest of Asia-Pacific Prostate Cancer Market
9.3.4.6.1. Rest of Asia-Pacific Prostate Cancer Market by Drug Class
9.3.4.6.2. Rest of Asia-Pacific Prostate Cancer Market by Distribution Channel
9.3.4.6.3. Rest of Asia-Pacific Prostate Cancer Market by End User
9.4. RoW
9.4.1. RoW Prostate Cancer Market by Drug Class
9.4.2. RoW Prostate Cancer Market by Distribution Channel
9.4.3. RoW Prostate Cancer Market by End User
9.4.4. RoW Prostate Cancer Market by Sub-region
9.4.4.1. Latin America Prostate Cancer Market
9.4.4.1.1. Latin America Prostate Cancer Market by Drug Class
9.4.4.1.2. Latin America Prostate Cancer Market by Distribution Channel
9.4.4.1.3. Latin America Prostate Cancer Market by End User
9.4.4.2. Middle East Prostate Cancer Market
9.4.4.2.1. Middle East Prostate Cancer Market by Drug Class
9.4.4.2.2. Middle East Prostate Cancer Market by Distribution Channel
9.4.4.2.3. Middle East Prostate Cancer Market by End User
9.4.4.3. Africa Prostate Cancer Market
9.4.4.3.1. Africa Prostate Cancer Market by Drug Class
9.4.4.3.2. Africa Prostate Cancer Market by Distribution Channel
9.4.4.3.3. Africa Prostate Cancer Market by End User

  • Not Sure / Need Reassuring
    • Confirm Content
      • Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:

        Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.

        Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.

        Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.

    • Sample Pages
      • With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.

        It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.

        To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.

    • Check for Alternatives
      • Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.

        To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.

  • Prices / Formats / Delivery
    • Prices
      • All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.

        Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.

    • Discounts
      • As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.

        Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.

        To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.

    • Available Currencies
      • Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.

        Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.

        To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.

    • Licenses
      • License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.

        If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.

    • Global Site License
      • The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.

        It is important to note that this may exclude Parent Companies or Subsidiaries.

        If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.

    • Formats
      • The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.

        If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.

    • Delivery
      • Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.

        Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.

        If a delay in delivery is expected you will be informed about it immediately.

    • Shipping Charges
      • As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.

        If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.

  • Ordering
    • By Credit Card
      • We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.

        Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.

        For more information on PayU please visit: https://www.payu.pl/en/about-us

    • By Money Transfer
      • If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.

        With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.

  • Security
    • Website security
      • We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.

        Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.

    • Credit Card Security
      • We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.

        PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.

PLEASE SELECT LICENSE